SIMILAR PATTERNS OF AMINO ACIDS FOR 2VCD_A_RAPA138_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1fd9 | PROTEIN (MACROPHAGEINFECTIVITYPOTENTIATOR PROTEIN) (Legionellapneumophila) |
PF00254(FKBP_C)PF01346(FKBP_N) | 5 | TYR A 131ASP A 142PHE A 153GLN A 154TRP A 162 | None | 1.30A | 2vcdA-1fd9A:20.3 | 2vcdA-1fd9A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1fd9 | PROTEIN (MACROPHAGEINFECTIVITYPOTENTIATOR PROTEIN) (Legionellapneumophila) |
PF00254(FKBP_C)PF01346(FKBP_N) | 10 | TYR A 131PHE A 141ASP A 142PHE A 153GLN A 157VAL A 158ILE A 159PRO A 160TRP A 162TYR A 185 | None | 0.93A | 2vcdA-1fd9A:20.3 | 2vcdA-1fd9A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1fkk | FK506 BINDINGPROTEIN (Bos taurus) |
PF00254(FKBP_C) | 7 | TYR A 26PHE A 36ASP A 37VAL A 55ILE A 56TRP A 59TYR A 82 | None | 0.98A | 2vcdA-1fkkA:13.6 | 2vcdA-1fkkA:35.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1jvw | MACROPHAGEINFECTIVITYPOTENTIATOR (Trypanosomacruzi) |
PF00254(FKBP_C) | 6 | TYR A 92PHE A 102ASP A 103ILE A 120TRP A 123TYR A 146 | None | 1.02A | 2vcdA-1jvwA:18.4 | 2vcdA-1jvwA:40.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1jvw | MACROPHAGEINFECTIVITYPOTENTIATOR (Trypanosomacruzi) |
PF00254(FKBP_C) | 6 | TYR A 92PHE A 102PHE A 114ILE A 120TRP A 123TYR A 146 | None | 0.98A | 2vcdA-1jvwA:18.4 | 2vcdA-1jvwA:40.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1jvw | MACROPHAGEINFECTIVITYPOTENTIATOR (Trypanosomacruzi) |
PF00254(FKBP_C) | 6 | TYR A 92PHE A 114VAL A 119ILE A 120TRP A 123TYR A 146 | None | 0.78A | 2vcdA-1jvwA:18.4 | 2vcdA-1jvwA:40.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1kt1 | FK506-BINDINGPROTEIN FKBP51 (Saimiriboliviensis) |
PF00254(FKBP_C)PF00515(TPR_1)PF13181(TPR_8) | 5 | TYR A 57GLN A 85VAL A 86ILE A 87TRP A 90 | None | 1.30A | 2vcdA-1kt1A:13.7 | 2vcdA-1kt1A:12.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1n1a | FKBP52 (Homo sapiens) |
PF00254(FKBP_C) | 7 | TYR A 57PHE A 67ASP A 68VAL A 86ILE A 87TRP A 90TYR A 113 | None | 0.83A | 2vcdA-1n1aA:14.3 | 2vcdA-1n1aA:33.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1pbk | FKBP25 (Homo sapiens) |
PF00254(FKBP_C) | 6 | TYR A 135PHE A 145ASP A 146VAL A 171ILE A 172TRP A 175 | RAP A 225 (-3.9A)RAP A 225 (-4.6A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A) | 0.75A | 2vcdA-1pbkA:13.4 | 2vcdA-1pbkA:31.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1pbk | FKBP25 (Homo sapiens) |
PF00254(FKBP_C) | 6 | TYR A 135PHE A 145VAL A 171ILE A 172TRP A 175TYR A 198 | RAP A 225 (-3.9A)RAP A 225 (-4.6A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A) | 0.94A | 2vcdA-1pbkA:13.4 | 2vcdA-1pbkA:31.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1q6h | FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKPA (Escherichiacoli) |
PF00254(FKBP_C)PF01346(FKBP_N) | 6 | PHE A 156ASP A 157PHE A 168ILE A 174TRP A 177TYR A 200 | None | 1.35A | 2vcdA-1q6hA:19.5 | 2vcdA-1q6hA:37.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1q6h | FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKPA (Escherichiacoli) |
PF00254(FKBP_C)PF01346(FKBP_N) | 8 | TYR A 146PHE A 156ASP A 157VAL A 173ILE A 174PRO A 175TRP A 177TYR A 200 | None | 1.05A | 2vcdA-1q6hA:19.5 | 2vcdA-1q6hA:37.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1r4a | ADP-RIBOSYLATIONFACTOR-LIKE PROTEIN1 (Rattusnorvegicus) |
PF00025(Arf) | 5 | TYR A 81PHE A 51VAL A 53TRP A 66VAL A 91 | None | 1.39A | 2vcdA-1r4aA:undetectable | 2vcdA-1r4aA:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1r9h | FK506 BINDINGPROTEIN FAMILY (Caenorhabditiselegans) |
PF00254(FKBP_C) | 7 | TYR A 40PHE A 50ASP A 51VAL A 69ILE A 70TRP A 73TYR A 96 | None | 0.93A | 2vcdA-1r9hA:14.7 | 2vcdA-1r9hA:28.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1r9h | FK506 BINDINGPROTEIN FAMILY (Caenorhabditiselegans) |
PF00254(FKBP_C) | 5 | TYR A 40PHE A 50PHE A 60TRP A 73TYR A 96 | None | 1.37A | 2vcdA-1r9hA:14.7 | 2vcdA-1r9hA:28.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1s0p | ADENYLYLCYCLASE-ASSOCIATEDPROTEIN (Dictyosteliumdiscoideum) |
PF01213(CAP_N) | 5 | TYR A 194GLN A 83VAL A 85ILE A 88VAL A 152 | None | 1.18A | 2vcdA-1s0pA:undetectable | 2vcdA-1s0pA:20.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1u79 | FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASE3 (Arabidopsisthaliana) |
PF00254(FKBP_C) | 7 | TYR A 37PHE A 47ASP A 48VAL A 66ILE A 67TRP A 70TYR A 99 | None | 0.93A | 2vcdA-1u79A:13.9 | 2vcdA-1u79A:33.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1u84 | HYPOTHETICAL PROTEIN (Geobacillusstearothermophilus) |
PF08958(DUF1871) | 5 | TYR A 27ASP A 18PHE A 59ILE A 63PRO A 64 | None | 1.38A | 2vcdA-1u84A:undetectable | 2vcdA-1u84A:21.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1we5 | PUTATIVE FAMILY 31GLUCOSIDASE YICI (Escherichiacoli) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 5 | TYR A 662ASP A 642PHE A 628GLN A 627VAL A 626 | None | 1.23A | 2vcdA-1we5A:undetectable | 2vcdA-1we5A:10.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1yat | FK506 BINDINGPROTEIN (Saccharomycescerevisiae) |
PF00254(FKBP_C) | 7 | TYR A 26PHE A 36ASP A 37VAL A 55ILE A 56TRP A 59TYR A 82 | FK5 A 108 ( 4.0A)FK5 A 108 ( 4.8A)FK5 A 108 ( 3.3A)FK5 A 108 ( 3.4A)FK5 A 108 ( 3.7A)FK5 A 108 ( 3.6A)FK5 A 108 ( 4.7A) | 0.91A | 2vcdA-1yatA:15.0 | 2vcdA-1yatA:31.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1yga | HYPOTHETICAL 37.9KDA PROTEIN INBIO3-HXT17INTERGENIC REGION (Saccharomycescerevisiae) |
PF01263(Aldose_epim) | 5 | TYR A 338PHE A 179GLN A 44VAL A 42VAL A 12 | None | 1.13A | 2vcdA-1ygaA:undetectable | 2vcdA-1ygaA:18.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2a7n | L(+)-MANDELATEDEHYDROGENASE (Pseudomonasputida;Spinaciaoleracea) |
PF01070(FMN_dh) | 5 | PHE A 287ASP A 292PHE A 49GLN A 354PRO A 350 | None | 1.36A | 2vcdA-2a7nA:undetectable | 2vcdA-2a7nA:17.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2bk9 | CG9734-PA (Drosophilamelanogaster) |
PF00042(Globin) | 5 | PHE A 143PHE A 31VAL A 112TYR A 139VAL A 138 | NoneHEM A1154 ( 3.9A)NoneNoneNone | 1.12A | 2vcdA-2bk9A:undetectable | 2vcdA-2bk9A:24.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2frg | TREM-LIKETRANSCRIPT-1 (Homo sapiens) |
no annotation | 5 | TYR P 102ASP P 98GLN P 88VAL P 36ILE P 34 | None | 1.46A | 2vcdA-2frgP:undetectable | 2vcdA-2frgP:22.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2in3 | HYPOTHETICAL PROTEIN (Nitrosomonaseuropaea) |
PF01323(DSBA) | 5 | ASP A 139VAL A 127ILE A 116PRO A 14VAL A 101 | None | 1.44A | 2vcdA-2in3A:undetectable | 2vcdA-2in3A:23.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2jgp | TYROCIDINESYNTHETASE 3 (Brevibacillusbrevis) |
PF00550(PP-binding)PF00668(Condensation) | 5 | PHE A 501PHE A 392GLN A 394ILE A 508PRO A 512 | None | 1.33A | 2vcdA-2jgpA:undetectable | 2vcdA-2jgpA:14.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2pbc | FK506-BINDINGPROTEIN 2 (Homo sapiens) |
PF00254(FKBP_C) | 7 | TYR A 56PHE A 66ASP A 67VAL A 85ILE A 86TRP A 89TYR A 112 | PEG A 201 (-4.4A)NoneNonePEG A 201 (-3.6A)PEG A 201 (-3.8A)PEG A 201 (-3.7A)None | 0.86A | 2vcdA-2pbcA:10.6 | 2vcdA-2pbcA:35.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2rhq | PHENYLALANYL-TRNASYNTHETASE BETACHAIN (Staphylococcushaemolyticus) |
PF01588(tRNA_bind)PF03147(FDX-ACB)PF03483(B3_4)PF03484(B5) | 5 | ASP B 10GLN B 162VAL B 163ILE B 3VAL B 185 | None | 1.43A | 2vcdA-2rhqB:undetectable | 2vcdA-2rhqB:10.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vn1 | 70 KDAPEPTIDYLPROLYLISOMERASE (Plasmodiumfalciparum) |
PF00254(FKBP_C) | 6 | TYR A 44PHE A 55ASP A 56VAL A 74ILE A 75TRP A 78 | FK5 A 501 (-4.1A)FK5 A 501 (-4.5A)FK5 A 501 (-3.4A)FK5 A 501 (-3.5A)FK5 A 501 (-4.3A)FK5 A 501 (-3.3A) | 0.76A | 2vcdA-2vn1A:14.6 | 2vcdA-2vn1A:30.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vn1 | 70 KDAPEPTIDYLPROLYLISOMERASE (Plasmodiumfalciparum) |
PF00254(FKBP_C) | 5 | TYR A 44VAL A 74ILE A 75TRP A 78TYR A 101 | FK5 A 501 (-4.1A)FK5 A 501 (-3.5A)FK5 A 501 (-4.3A)FK5 A 501 (-3.3A)FK5 A 501 (-4.7A) | 0.75A | 2vcdA-2vn1A:14.6 | 2vcdA-2vn1A:30.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2we5 | CARBAMATE KINASE 1 (Enterococcusfaecalis) |
PF00696(AA_kinase) | 5 | ASP A 120GLN A 113VAL A 114ILE A 207VAL A 161 | None | 1.40A | 2vcdA-2we5A:undetectable | 2vcdA-2we5A:17.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ww2 | ALPHA-1,2-MANNOSIDASE (Bacteroidesthetaiotaomicron) |
PF07971(Glyco_hydro_92) | 5 | TYR A 98ASP A 349PHE A 258GLN A 263VAL A 55 | None | 1.44A | 2vcdA-2ww2A:undetectable | 2vcdA-2ww2A:11.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2x24 | ACETYL-COACARBOXYLASE (Bos taurus) |
PF01039(Carboxyl_trans) | 5 | PHE A 469ASP A 468VAL A 319TRP A 334VAL A 408 | None | 1.25A | 2vcdA-2x24A:undetectable | 2vcdA-2x24A:10.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2y78 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Burkholderiapseudomallei) |
PF00254(FKBP_C) | 5 | TYR A 33ASP A 44ILE A 63TRP A 66TYR A 89 | None | 0.91A | 2vcdA-2y78A:15.2 | 2vcdA-2y78A:34.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2y78 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Burkholderiapseudomallei) |
PF00254(FKBP_C) | 5 | TYR A 33PHE A 43ASP A 44ILE A 63TRP A 66 | None | 0.90A | 2vcdA-2y78A:15.2 | 2vcdA-2y78A:34.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2y78 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Burkholderiapseudomallei) |
PF00254(FKBP_C) | 5 | TYR A 33PHE A 43VAL A 62ILE A 63TRP A 66 | None | 0.75A | 2vcdA-2y78A:15.2 | 2vcdA-2y78A:34.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2y78 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Burkholderiapseudomallei) |
PF00254(FKBP_C) | 5 | TYR A 33VAL A 62ILE A 63TRP A 66TYR A 89 | None | 0.81A | 2vcdA-2y78A:15.2 | 2vcdA-2y78A:34.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zsj | THREONINE SYNTHASE (Aquifexaeolicus) |
PF00291(PALP) | 5 | PHE A 201VAL A 188ILE A 186PRO A 187VAL A 314 | NonePLP A1101 (-4.0A)NoneNoneNone | 1.36A | 2vcdA-2zsjA:undetectable | 2vcdA-2zsjA:17.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3c75 | METHYLAMINEDEHYDROGENASE HEAVYCHAIN (Paracoccusversutus) |
PF06433(Me-amine-dh_H) | 5 | PHE H 246PHE H 272GLN H 179ILE H 224VAL H 205 | None | 1.41A | 2vcdA-3c75H:undetectable | 2vcdA-3c75H:14.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3h5t | TRANSCRIPTIONALREGULATOR, LACIFAMILY (Corynebacteriumglutamicum) |
PF00356(LacI)PF13377(Peripla_BP_3) | 5 | TYR A 135ASP A 158GLN A 97VAL A 95VAL A 345 | None | 1.15A | 2vcdA-3h5tA:undetectable | 2vcdA-3h5tA:16.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hmj | FATTY ACID SYNTHASESUBUNIT ALPHA (Saccharomycescerevisiae) |
PF00109(ketoacyl-synt)PF01648(ACPS)PF02801(Ketoacyl-synt_C) | 5 | ASP A 764VAL A 822ILE A 768PRO A 770VAL A 703 | None | 1.30A | 2vcdA-3hmjA:undetectable | 2vcdA-3hmjA:6.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3krb | ALDOSE REDUCTASE (Giardiaintestinalis) |
PF00248(Aldo_ket_red) | 5 | TYR A 40ASP A 35VAL A 19ILE A 46VAL A 66 | UNX A 402 (-4.4A)NAP A 400 (-3.7A)NoneNoneNone | 1.41A | 2vcdA-3krbA:undetectable | 2vcdA-3krbA:18.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3l9d | PUTATIVE GTPPYROPHOSPHOKINASE (Streptococcusmutans) |
PF04607(RelA_SpoT) | 5 | ASP A 96GLN A 101VAL A 119ILE A 138VAL A 14 | None | 1.28A | 2vcdA-3l9dA:undetectable | 2vcdA-3l9dA:17.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3n91 | UNCHARACTERIZEDPROTEIN (Bacteroidesovatus) |
PF08522(DUF1735) | 5 | GLN A 158VAL A 80ILE A 120PRO A 121VAL A 129 | None | 1.22A | 2vcdA-3n91A:undetectable | 2vcdA-3n91A:20.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3o5d | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 7 | TYR A 57PHE A 67ASP A 68VAL A 86ILE A 87TRP A 90TYR A 113 | None | 1.01A | 2vcdA-3o5dA:14.2 | 2vcdA-3o5dA:21.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3o5e | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 5 | TYR A 57PHE A 67ASP A 68ILE A 87TYR A 113 | None | 0.82A | 2vcdA-3o5eA:14.8 | 2vcdA-3o5eA:27.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3o5e | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 5 | TYR A 57VAL A 86ILE A 87TRP A 90TYR A 113 | None | 0.77A | 2vcdA-3o5eA:14.8 | 2vcdA-3o5eA:27.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3pa7 | 70 KDAPEPTIDYLPROLYLISOMERASE, PUTATIVE (Plasmodiumvivax) |
PF00254(FKBP_C) | 7 | TYR A 43PHE A 54ASP A 55VAL A 73ILE A 74TRP A 77TYR A 100 | None | 0.86A | 2vcdA-3pa7A:14.7 | 2vcdA-3pa7A:32.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3pa7 | 70 KDAPEPTIDYLPROLYLISOMERASE, PUTATIVE (Plasmodiumvivax) |
PF00254(FKBP_C) | 5 | TYR A 43PHE A 54PHE A 64TRP A 77TYR A 100 | None | 1.35A | 2vcdA-3pa7A:14.7 | 2vcdA-3pa7A:32.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3vsv | XYLOSIDASE (Thermoanaerobacteriumsaccharolyticum) |
PF13229(Beta_helix) | 5 | TYR A 411PHE A 475ASP A 473VAL A 402VAL A 489 | None | 1.30A | 2vcdA-3vsvA:undetectable | 2vcdA-3vsvA:13.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4aut | DECAPRENYL-PHOSPHORYL-BETA-D-RIBOFURANOSE-2-OXIDOREDUCTASE (Mycolicibacteriumsmegmatis) |
PF01565(FAD_binding_4)PF04030(ALO) | 5 | PHE A 457PHE A 14VAL A 42ILE A 43PRO A 40 | None | 1.31A | 2vcdA-4autA:undetectable | 2vcdA-4autA:16.34 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4bf8 | FPR4 (Saccharomycescerevisiae) |
PF00254(FKBP_C) | 6 | TYR A 313PHE A 323ASP A 324VAL A 341ILE A 342TRP A 345 | None | 0.88A | 2vcdA-4bf8A:14.2 | 2vcdA-4bf8A:30.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4dvh | SUPEROXIDE DISMUTASE (Trypanosomacruzi) |
PF00081(Sod_Fe_N)PF02777(Sod_Fe_C) | 5 | PHE A 20PHE A 115VAL A 116TRP A 185TYR A 180 | None | 1.45A | 2vcdA-4dvhA:undetectable | 2vcdA-4dvhA:20.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4dz3 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Burkholderiapseudomallei) |
PF00254(FKBP_C) | 6 | TYR A 33PHE A 43ASP A 44VAL A 62ILE A 63TRP A 66 | FK5 A 201 ( 3.9A)FK5 A 201 (-4.8A)FK5 A 201 (-3.5A)FK5 A 201 ( 3.6A)FK5 A 201 (-3.8A)FK5 A 201 (-3.4A) | 0.82A | 2vcdA-4dz3A:15.2 | 2vcdA-4dz3A:34.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4dz3 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Burkholderiapseudomallei) |
PF00254(FKBP_C) | 6 | TYR A 33PHE A 43VAL A 62ILE A 63TRP A 66TYR A 89 | FK5 A 201 ( 3.9A)FK5 A 201 (-4.8A)FK5 A 201 ( 3.6A)FK5 A 201 (-3.8A)FK5 A 201 (-3.4A)FK5 A 201 (-4.7A) | 0.90A | 2vcdA-4dz3A:15.2 | 2vcdA-4dz3A:34.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4el1 | PROTEINDISULFIDE-ISOMERASE (Homo sapiens) |
PF00085(Thioredoxin)PF13848(Thioredoxin_6) | 5 | PHE A 249PHE A 275VAL A 237ILE A 238PRO A 235 | None | 1.39A | 2vcdA-4el1A:undetectable | 2vcdA-4el1A:14.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4iqc | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1B (Homo sapiens) |
PF00254(FKBP_C) | 5 | PHE A 36ASP A 37GLN A 53ILE A 56TYR A 82 | None | 1.34A | 2vcdA-4iqcA:13.6 | 2vcdA-4iqcA:29.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4iqc | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1B (Homo sapiens) |
PF00254(FKBP_C) | 5 | TYR A 26PHE A 36ASP A 37ILE A 56TYR A 82 | None | 0.95A | 2vcdA-4iqcA:13.6 | 2vcdA-4iqcA:29.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homo sapiens) |
PF00254(FKBP_C) | 7 | TYR A 57PHE A 67ASP A 68VAL A 86ILE A 87TRP A 90TYR A 113 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)None | 0.80A | 2vcdA-4lawA:14.0 | 2vcdA-4lawA:23.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homo sapiens) |
PF00254(FKBP_C) | 5 | TYR A 57PHE A 67PHE A 77TRP A 90TYR A 113 | NoneNoneNoneDMS A 304 ( 4.0A)None | 1.29A | 2vcdA-4lawA:14.0 | 2vcdA-4lawA:23.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4lhu | 9C2 TCR DELTA CHAIN9C2 TCR GAMMA CHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 5 | ASP D 164GLN G 182VAL D 168ILE D 167VAL D 193 | None | 1.38A | 2vcdA-4lhuD:undetectable | 2vcdA-4lhuD:22.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4nnr | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP2 (Homo sapiens) |
PF00254(FKBP_C) | 5 | PHE A 66ASP A 67VAL A 85ILE A 86TRP A 89 | FK5 A 201 (-4.7A)FK5 A 201 (-3.4A)FK5 A 201 (-3.4A)FK5 A 201 (-3.8A)FK5 A 201 (-3.5A) | 0.66A | 2vcdA-4nnrA:10.6 | 2vcdA-4nnrA:30.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4nnr | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP2 (Homo sapiens) |
PF00254(FKBP_C) | 5 | PHE A 66VAL A 85ILE A 86TRP A 89TYR A 112 | FK5 A 201 (-4.7A)FK5 A 201 (-3.4A)FK5 A 201 (-3.8A)FK5 A 201 (-3.5A)FK5 A 201 (-4.5A) | 0.94A | 2vcdA-4nnrA:10.6 | 2vcdA-4nnrA:30.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4nnr | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP2 (Homo sapiens) |
PF00254(FKBP_C) | 5 | TYR A 56ASP A 67VAL A 85ILE A 86TRP A 89 | FK5 A 201 (-4.1A)FK5 A 201 (-3.4A)FK5 A 201 (-3.4A)FK5 A 201 (-3.8A)FK5 A 201 (-3.5A) | 0.75A | 2vcdA-4nnrA:10.6 | 2vcdA-4nnrA:30.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4nnr | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP2 (Homo sapiens) |
PF00254(FKBP_C) | 5 | TYR A 56VAL A 85ILE A 86TRP A 89TYR A 112 | FK5 A 201 (-4.1A)FK5 A 201 (-3.4A)FK5 A 201 (-3.8A)FK5 A 201 (-3.5A)FK5 A 201 (-4.5A) | 0.62A | 2vcdA-4nnrA:10.6 | 2vcdA-4nnrA:30.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4p05 | ARYLSULFATESULFOTRANSFERASEASST (Escherichiacoli) |
PF05935(Arylsulfotrans)PF17425(Arylsulfotran_N) | 5 | TYR A 433PHE A 429ASP A 430TYR A 473VAL A 485 | None | 1.41A | 2vcdA-4p05A:undetectable | 2vcdA-4p05A:12.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4r0x | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 5 | TYR A 57GLN A 85VAL A 86ILE A 87TYR A 113 | None | 1.30A | 2vcdA-4r0xA:14.8 | 2vcdA-4r0xA:30.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4r0x | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 5 | TYR A 57PHE A 67VAL A 86ILE A 87TRP A 90 | None | 0.83A | 2vcdA-4r0xA:14.8 | 2vcdA-4r0xA:30.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4r0x | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 5 | TYR A 57VAL A 86ILE A 87TRP A 90TYR A 113 | None | 0.85A | 2vcdA-4r0xA:14.8 | 2vcdA-4r0xA:30.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4txv | CYTOCHROME C OXIDASESUBUNIT 2 (Bradyrhizobiumdiazoefficiens) |
PF00116(COX2) | 5 | PHE B 156VAL B 185ILE B 135TYR B 148VAL B 256 | None | 1.46A | 2vcdA-4txvB:undetectable | 2vcdA-4txvB:22.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4u10 | POLY-BETA-1,6-N-ACETYL-D-GLUCOSAMINEN-DEACETYLASE (Aggregatibacteractinomycetemcomitans) |
PF01522(Polysacc_deac_1) | 5 | TYR A 204PHE A 212GLN A 184VAL A 176VAL A 124 | None | 1.44A | 2vcdA-4u10A:undetectable | 2vcdA-4u10A:18.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4uoz | BETA-GALACTOSIDASE (Bifidobacteriumanimalis) |
PF02449(Glyco_hydro_42)PF08532(Glyco_hydro_42M)PF08533(Glyco_hydro_42C) | 5 | PHE A 493ASP A 469VAL A 479ILE A 476VAL A 527 | None | 1.44A | 2vcdA-4uozA:undetectable | 2vcdA-4uozA:11.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wgk | NEUTRAL CERAMIDASE (Homo sapiens) |
PF04734(Ceramidase_alk)PF17048(Ceramidse_alk_C) | 5 | TYR A 591PHE A 456ILE A 597PRO A 450VAL A 575 | PO4 A 810 (-4.4A)NoneNoneNoneNone | 1.28A | 2vcdA-4wgkA:undetectable | 2vcdA-4wgkA:12.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4zon | VERRUCULOGENSYNTHASE (Aspergillusfumigatus) |
PF05721(PhyH) | 5 | TYR A 224ASP A 131PHE A 115VAL A 221PRO A 155 | 4Q1 A 401 (-3.6A)FE2 A 402 ( 2.8A)4Q1 A 401 (-3.8A)NoneNone | 1.31A | 2vcdA-4zonA:undetectable | 2vcdA-4zonA:19.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5b8i | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Coccidioidesimmitis) |
PF00254(FKBP_C) | 5 | PHE C 55ASP C 56VAL C 73ILE C 74TRP C 77 | FK5 C 201 ( 4.8A)FK5 C 201 ( 3.8A)FK5 C 201 (-3.5A)FK5 C 201 (-3.8A)FK5 C 201 (-3.4A) | 0.73A | 2vcdA-5b8iC:12.8 | 2vcdA-5b8iC:30.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5b8i | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Coccidioidesimmitis) |
PF00254(FKBP_C) | 5 | PHE C 55VAL C 73ILE C 74TRP C 77TYR C 100 | FK5 C 201 ( 4.8A)FK5 C 201 (-3.5A)FK5 C 201 (-3.8A)FK5 C 201 (-3.4A)FK5 C 201 (-4.5A) | 0.92A | 2vcdA-5b8iC:12.8 | 2vcdA-5b8iC:30.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5b8i | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Coccidioidesimmitis) |
PF00254(FKBP_C) | 5 | TYR C 36ASP C 56VAL C 73ILE C 74TRP C 77 | FK5 C 201 (-4.1A)FK5 C 201 ( 3.8A)FK5 C 201 (-3.5A)FK5 C 201 (-3.8A)FK5 C 201 (-3.4A) | 0.86A | 2vcdA-5b8iC:12.8 | 2vcdA-5b8iC:30.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5b8i | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Coccidioidesimmitis) |
PF00254(FKBP_C) | 5 | TYR C 36VAL C 73ILE C 74TRP C 77TYR C 100 | FK5 C 201 (-4.1A)FK5 C 201 (-3.5A)FK5 C 201 (-3.8A)FK5 C 201 (-3.4A)FK5 C 201 (-4.5A) | 0.68A | 2vcdA-5b8iC:12.8 | 2vcdA-5b8iC:30.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5bnd | ABC TRANSPORTER,ATP-BINDING PROTEIN (Staphylococcusepidermidis) |
no annotation | 5 | PHE A 398ILE A 463PRO A 464TRP A 500TYR A 409 | None | 1.34A | 2vcdA-5bndA:undetectable | 2vcdA-5bndA:24.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5c54 | DIHYDRODIPICOLINATESYNTHASE/N-ACETYLNEURAMINATE LYASE (Corynebacteriumglutamicum) |
PF00701(DHDPS) | 5 | PHE A 44PHE A 110VAL A 144ILE A 140PRO A 141 | None | 1.43A | 2vcdA-5c54A:undetectable | 2vcdA-5c54A:19.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5foh | POLYSACCHARIDEMONOOXYGENASE (Neurosporacrassa) |
PF03443(Glyco_hydro_61) | 5 | PHE A 106VAL A 173ILE A 172TYR A 143VAL A 92 | None | 1.43A | 2vcdA-5fohA:undetectable | 2vcdA-5fohA:23.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5gmt | ALGINATE LYASE (Aplysia kurodai) |
no annotation | 5 | PHE A 172GLN A 209VAL A 202ILE A 182TYR A 85 | None | 1.44A | 2vcdA-5gmtA:undetectable | 2vcdA-5gmtA:21.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5i7p | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A,FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD,PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A (Escherichiacoli;Homo sapiens) |
PF00254(FKBP_C) | 7 | TYR A 26PHE A 36ASP A 37VAL A 55ILE A 56TRP A 59TYR A 82 | None | 0.90A | 2vcdA-5i7pA:13.2 | 2vcdA-5i7pA:26.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5i7q | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A,FKBP-TYPE 16KDA PEPTIDYL-PROLYLCIS-TRANSISOMERASE,PEPTIDYL-PROLYL CIS-TRANSISOMERASE FKBP1A (Escherichiacoli;Homo sapiens) |
PF00254(FKBP_C) | 7 | TYR A 26PHE A 36ASP A 37VAL A 55ILE A 56TRP A 59TYR A 82 | None | 0.95A | 2vcdA-5i7qA:12.9 | 2vcdA-5i7qA:28.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i98 | FK506-BINDINGPROTEIN 1 (Candidaalbicans) |
PF00254(FKBP_C) | 8 | TYR A 30PHE A 40ASP A 41GLN A 58VAL A 59ILE A 60TRP A 63TYR A 97 | None | 1.24A | 2vcdA-5i98A:13.5 | 2vcdA-5i98A:35.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5j6e | FK506-BINDINGPROTEIN 1A (Aspergillusfumigatus) |
PF00254(FKBP_C) | 7 | TYR A 27PHE A 37ASP A 38VAL A 56ILE A 57TRP A 60TYR A 83 | None | 0.96A | 2vcdA-5j6eA:14.4 | 2vcdA-5j6eA:30.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5nju | GENOME POLYPROTEIN (Zika virus) |
no annotation | 5 | TYR A 119GLN A 98VAL A 97ILE A 94PRO A 73 | None | 1.24A | 2vcdA-5njuA:undetectable | 2vcdA-5njuA:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5tiz | SULFOTRANSFERASE (Schistosomajaponicum) |
no annotation | 5 | TYR A 47GLN A 53ILE A 41TYR A 36VAL A 85 | None | 1.44A | 2vcdA-5tizA:undetectable | 2vcdA-5tizA:22.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5tmh | POLYPROTEIN (Zika virus) |
PF00972(Flavi_NS5)PF01728(FtsJ) | 5 | TYR A 119GLN A 98VAL A 97ILE A 94PRO A 73 | None | 1.44A | 2vcdA-5tmhA:undetectable | 2vcdA-5tmhA:9.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5v8t | UBIQUITIN-LIKEPROTEINSMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Burkholderiapseudomallei;Saccharomycescerevisiae) |
no annotation | 7 | TYR A 33PHE A 43ASP A 44VAL A 62ILE A 63TRP A 66TYR A 89 | 8ZV A 201 (-3.8A)8ZV A 201 (-4.8A)8ZV A 201 (-3.9A)8ZV A 201 (-3.6A)8ZV A 201 (-4.0A)8ZV A 201 (-3.3A)8ZV A 201 (-4.6A) | 0.99A | 2vcdA-5v8tA:15.7 | 2vcdA-5v8tA:18.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wka | BETA-GLUCOSIDASE (metagenome) |
no annotation | 5 | ASP A 60PHE A 96GLN A 98PRO A 113TYR A 72 | None | 1.44A | 2vcdA-5wkaA:undetectable | 2vcdA-5wkaA:21.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wrj | PROTEIN-TYROSINESULFOTRANSFERASE 1 (Homo sapiens) |
PF13469(Sulfotransfer_3) | 5 | ASP A 185GLN A 312VAL A 310ILE A 306PRO A 307 | None | 1.37A | 2vcdA-5wrjA:undetectable | 2vcdA-5wrjA:17.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wxi | EARP (Neisseriameningitidis) |
no annotation | 5 | ASP A 256PHE A 362GLN A 364PRO A 368VAL A 23 | None | 1.41A | 2vcdA-5wxiA:undetectable | 2vcdA-5wxiA:16.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringae groupgenomosp. 3) |
PF00254(FKBP_C) | 8 | TYR A 147PHE A 157ASP A 158PHE A 166VAL A 171ILE A 172TRP A 175TYR A 198 | TLA A 301 ( 4.4A)NoneTLA A 301 (-3.7A)TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)None | 1.01A | 2vcdA-5xb0A:19.0 | 2vcdA-5xb0A:40.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ybb | RESTRICTIONENDONUCLEASE SSUBUNITS (Caldanaerobactersubterraneus) |
no annotation | 5 | PHE D 252ASP D 251GLN D 267ILE D 295VAL D 279 | None | 1.23A | 2vcdA-5ybbD:undetectable | 2vcdA-5ybbD:17.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6b4p | PEPTIDYLPROLYLISOMERASE (Naegleriafowleri) |
no annotation | 6 | TYR A 38PHE A 48ASP A 49VAL A 67ILE A 68TRP A 71 | None | 0.87A | 2vcdA-6b4pA:14.7 | 2vcdA-6b4pA:32.37 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6b4p | PEPTIDYLPROLYLISOMERASE (Naegleriafowleri) |
no annotation | 5 | TYR A 38VAL A 67ILE A 68TRP A 71TYR A 94 | None | 0.82A | 2vcdA-6b4pA:14.7 | 2vcdA-6b4pA:32.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6fyd | PUTATIVEFAD-DEPENDENTOXYGENASE ENCM (Streptomycesmaritimus) |
no annotation | 5 | PHE A 453PHE A 204VAL A 167ILE A 169VAL A 58 | None | 1.33A | 2vcdA-6fydA:undetectable | 2vcdA-6fydA:19.71 |